<DOC>
	<DOCNO>NCT00696722</DOCNO>
	<brief_summary>The purpose study determine whether atazanavir use influence endothelial dysfunction associate type 2 diabetes mellitus .</brief_summary>
	<brief_title>Effects Atazanavir Treatment Type 2 Diabetes Mellitus Related Endothelial Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Inclusion Criteria ( important ) : 18 70 year type 2 diabetes mellitus treat diet , oral medication and/or insulin BMI 18 35 determinant renal hepatic function within twice upper limit normal range , abnormality lipid profile permit Exclusion Criteria ( important ) : history smoking within past year history current abuse drug , alcohol solvent current use antihypertensive , cardiac vasoactive medication clinical evidence cardiac pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>